Globus Medical (GMED) Common Equity (2011 - 2026)

Globus Medical's Common Equity history runs 16 years deep, the most recent figure standing at $4.7 billion for Q1 2026.

• Quarterly Common Equity rose 15.76% year-over-year to $4.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 billion (up 15.76% YoY) and the FY2025 annual result came in at $4.6 billion, up 9.48% from the prior year.
• Common Equity was $4.7 billion for Q1 2026 at Globus Medical, up from $4.6 billion in the prior quarter.
• Across five years, Common Equity topped out at $4.7 billion in Q1 2026 and bottomed at $1.7 billion in Q2 2022.
• A 5-year average of $3.4 billion and a median of $4.0 billion in 2023 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2023 — Common Equity surged 137.36% — and 2024, when it dropped 2.82%.
• Globus Medical's Common Equity stood at $1.8 billion in 2022, then soared by 116.53% to $4.0 billion in 2023, then gained by 4.49% to $4.2 billion in 2024, then gained by 9.48% to $4.6 billion in 2025, then climbed by 3.48% to $4.7 billion in 2026.
• Business Quant data shows GMED's Common Equity at $4.7 billion in Q1 2026, $4.6 billion in Q4 2025, and $4.4 billion in Q3 2025.